Skip to content

Efficacy Evaluation of Traditional Chinese Medicine JITAI Combined Comprehensive Model Among Heroin Addicts After Detoxification

Efficacy Evaluation of Traditional Chinese Medicine JITAI Combined Comprehensive Model Among Heroin Addicts After Detoxification

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01580163
Enrollment
554
Registered
2012-04-18
Start date
2009-09-30
Completion date
2013-08-31
Last updated
2015-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heroin Addiction

Keywords

the opioid dependence in rehabilitation phase, community

Brief summary

The purpose of this research is to observe the efficacy of comprehensive treatment model to improve treatment compliance and relapse prevention.

Detailed description

The model include the Chinese traditional medicine JITAI combined with psychological intervention and social support for maintenance therapy after acute detoxification of heroin addicts.On the basis of the existing community management experience and community of professional anti-drug community service,The investigator will adopt the Chinese traditional medicine JITAI combined with psychological intervention and social support for maintenance therapy after acute detoxification of the community of heroin addicts.The purpose is to observe the comprehensive treatment model to improve treatment compliance and relapse prevention,then the investigator will form a new model of community humane drug treatment.

Interventions

tablet,Each tablet weight 0.4g

DRUGMethadone

Oral Solution,1mg/ml

DRUGTraditional Chinese Medicine JITAI

tablet,Each tablet weight 0.4g

Sponsors

Shanghai Center of Biomedicine Development
CollaboratorUNKNOWN
Shanghai Mental Health Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Clinical Diagnosis of The opioid dependence * After detoxification.

Exclusion criteria

: * Clinical Diagnosis of glaucoma and other severe mental disorder; * serious organic disease within three months; * can not comply with the test requirements; * accept Hans therapy instrument; * have tendence of suicide,self-injury and impulse; * ECG abnormalities; * ALT or AST greater than 5 times the upper limit of normal; * history of epilepsy; * Lactating or pregnant women,or women of childbearing age fails to take effective contraceptive measures; * serious history of drug allergy or known allergy on traditional Chinese medicine JITAI; * Study before the withdrawal less than a half-life of 5.

Design outcomes

Primary

MeasureTime frameDescription
The drug use pattern during observation periodBaseline ,26 weeks and 52 weeksThe investigator will ues NHI(Nature History Interview) to describe the drug use pattern and and compare the different change among different groups during observation period

Secondary

MeasureTime frameDescription
The change of ASI(Addiction Severity Index) after the treatment and observationBaseline,26weeks and 52 weeksThe investigator will use ASI to describe the addiction severity of objects and compare the different change among different groups during observation period.
the change of drug use pattern during observation periodBaseline,26weeks and 52 weeksThe investigator will ues NHI(Nature History Interview) to describe the drug use pattern and and compare the different change among different groups during observation period.
the change of SF-36(the MOS item short form health survey) after treatment and observationBaseline,26 weeks and 52 weeksThe investigator will use SF-36 to describe the health status of objects and compare the different change among different groups during observation period.
the change of SAS(Self-Rating Anxiety Scale) and SDS(Self-rating Depression Scale) during observation periodBaseline ,26weeks and 52 weeksThe investigator will use SAS and SDS to describe the anxiety status and depression status then compare the different change among different groups during observation period.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026